{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:24:42Z","timestamp":1787145882541,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005024","name":"Beijing Postdoctoral Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92059207"],"award-info":[{"award-number":["92059207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930048"],"award-info":[{"award-number":["81930048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAS Youth Interdisciplinary Team","award":["JCTD-2021-08"],"award-info":[{"award-number":["JCTD-2021-08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04403-1","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:01:19Z","timestamp":1777726879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-modality imaging enables longitudinal biodistribution profiling of intracerebroventricular CAR-T therapy in orthotopic glioma"],"prefix":"10.1007","volume":"75","author":[{"given":"Chunzhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangxiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenju","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-3405","authenticated-orcid":false,"given":"Zhenhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8044-9040","authenticated-orcid":false,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9001-8858","authenticated-orcid":false,"given":"Nan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"4403_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2023) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020. Neuro Oncol 25:iv1\u2013iv99. https:\/\/doi.org\/10.1093\/neuonc\/noad149","journal-title":"Neuro Oncol"},{"key":"4403_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller KD, Ostrom QT, Kruchko C et al (2021) Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin 71:381\u2013406. https:\/\/doi.org\/10.3322\/caac.21693","journal-title":"CA Cancer J Clin"},{"key":"4403_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","volume":"3","author":"N Ahmed","year":"2017","unstructured":"Ahmed N, Brawley V, Hegde M et al (2017) HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. JAMA Oncol 3:1094\u20131101. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0184","journal-title":"JAMA Oncol"},{"key":"4403_CR4","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41591-021-01404-8","volume":"27","author":"NA Vitanza","year":"2021","unstructured":"Vitanza NA, Johnson AJ, Wilson AL et al (2021) Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis. Nat Med 27:1544\u20131552. https:\/\/doi.org\/10.1038\/s41591-021-01404-8","journal-title":"Nat Med"},{"key":"4403_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa0984","author":"DM O'Rourke","year":"2017","unstructured":"O\u2019Rourke DM, Nasrallah MP, Desai A et al (2017) A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaa0984","journal-title":"Sci Transl Med"},{"key":"4403_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41591-020-0821-8","volume":"26","author":"J Theruvath","year":"2020","unstructured":"Theruvath J, Sotillo E, Mount CW et al (2020) Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid\/rhabdoid tumors. Nat Med 26:712\u2013719. https:\/\/doi.org\/10.1038\/s41591-020-0821-8","journal-title":"Nat Med"},{"key":"4403_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","volume":"30","author":"CE Brown","year":"2024","unstructured":"Brown CE, Hibbard JC, Alizadeh D et al (2024) Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. Nat Med 30:1001\u20131012. https:\/\/doi.org\/10.1038\/s41591-024-02875-1","journal-title":"Nat Med"},{"key":"4403_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11060-024-04909-7","volume":"171","author":"EP Grewal","year":"2025","unstructured":"Grewal EP, Nahed BV, Carter BS, Gerstner ER, Curry WT, Maus MV, Choi BD (2025) Clinical progress in the development of CAR T cells to treat malignant glioma. J Neurooncol 171:571\u2013579. https:\/\/doi.org\/10.1007\/s11060-024-04909-7","journal-title":"J Neurooncol"},{"key":"4403_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda SM (2024) CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat Rev Clin Oncol 21:47\u201366. https:\/\/doi.org\/10.1038\/s41571-023-00832-4","journal-title":"Nat Rev Clin Oncol"},{"key":"4403_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799206","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li Y, Cao W et al (2021) Single-cell analysis of target antigens of CAR-T reveals a potential landscape of \u201cOn-Target, Off-Tumor Toxicity.\u201d Front Immunol 12:799206. https:\/\/doi.org\/10.3389\/fimmu.2021.799206","journal-title":"Front Immunol"},{"key":"4403_CR11","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/S1470-2045(19)30461-9","volume":"20","author":"I Minn","year":"2019","unstructured":"Minn I, Rowe SP, Pomper MG (2019) Enhancing CAR T-cell therapy through cellular imaging and radiotherapy. Lancet Oncol 20:e443\u2013e451. https:\/\/doi.org\/10.1016\/S1470-2045(19)30461-9","journal-title":"Lancet Oncol"},{"key":"4403_CR12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H, Lathia JD, Chen P (2024) Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol 21:1354\u20131375. https:\/\/doi.org\/10.1038\/s41423-024-01226-x","journal-title":"Cell Mol Immunol"},{"key":"4403_CR13","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.ymthe.2025.03.004","volume":"33","author":"SL Begley","year":"2025","unstructured":"Begley SL, O\u2019Rourke DM, Binder ZA (2025) CAR T cell therapy for glioblastoma: a review of the first decade of clinical trials. Mol Ther 33:2454\u20132461. https:\/\/doi.org\/10.1016\/j.ymthe.2025.03.004","journal-title":"Mol Ther"},{"key":"4403_CR14","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41591-025-03745-0","volume":"31","author":"SJ Bagley","year":"2025","unstructured":"Bagley SJ, Desai AS, Fraietta JA et al (2025) Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13R\u03b12 in recurrent glioblastoma: a phase 1 trial. Nat Med 31:2778\u20132787. https:\/\/doi.org\/10.1038\/s41591-025-03745-0","journal-title":"Nat Med"},{"key":"4403_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","volume":"31","author":"NA Vitanza","year":"2025","unstructured":"Vitanza NA, Ronsley R, Choe M et al (2025) Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial. Nat Med 31:861\u2013868. https:\/\/doi.org\/10.1038\/s41591-024-03451-3","journal-title":"Nat Med"},{"key":"4403_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02177-z","volume":"10","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Niu Y, Li Y, Xia C, Chen Z, Chen Y, Feng H (2025) Meningeal lymphatic drainage: novel insights into central nervous system disease. Signal Transduct Target Ther 10:142. https:\/\/doi.org\/10.1038\/s41392-025-02177-z","journal-title":"Signal Transduct Target Ther"},{"key":"4403_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114609","author":"A Mariniello","year":"2026","unstructured":"Mariniello A, Migliorini D (2026) CAR-T cell therapies are coming after glioblastoma: an overview of early phase clinical trials and future perspectives. iScience. https:\/\/doi.org\/10.1016\/j.isci.2025.114609","journal-title":"iScience"},{"key":"4403_CR18","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.7150\/thno.87248","volume":"13","author":"J Hunger","year":"2023","unstructured":"Hunger J, Schregel K, Boztepe B et al (2023) In vivo nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma. Theranostics 13:5170\u20135182. https:\/\/doi.org\/10.7150\/thno.87248","journal-title":"Theranostics"},{"key":"4403_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102363119","author":"L Kiru","year":"2022","unstructured":"Kiru L, Zlitni A, Tousley AM et al (2022) In vivo imaging of nanoparticle-labeled CAR T cells. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2102363119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4403_CR20","doi-asserted-by":"publisher","first-page":"120630","DOI":"10.1016\/j.biomaterials.2020.120630","volume":"269","author":"S Harmsen","year":"2021","unstructured":"Harmsen S, Medine EI, Moroz M et al (2021) A dual-modal PET\/near infrared fluorescent nanotag for long-term immune cell tracking. Biomaterials 269:120630. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120630","journal-title":"Biomaterials"},{"key":"4403_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag2196","author":"KV Keu","year":"2017","unstructured":"Keu KV, Witney TH, Yaghoubi S et al (2017) Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aag2196","journal-title":"Sci Transl Med"},{"key":"4403_CR22","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.59717\/j.xinn-med.2025.100137","volume":"3","author":"J Li","year":"2025","unstructured":"Li J, Ma J, Wang L et al (2025) Application of non-invasive imaging on cell tracking of adoptive cell therapy: a systemic review. Innov Med 3:100137. https:\/\/doi.org\/10.59717\/j.xinn-med.2025.100137","journal-title":"Innov Med"},{"key":"4403_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00892-0","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Du Y, Shi X et al (2024) NIR-II light in clinical oncology: opportunities and challenges. Nat Rev Clin Oncol. https:\/\/doi.org\/10.1038\/s41571-024-00892-0","journal-title":"Nat Rev Clin Oncol"},{"key":"4403_CR24","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00259-024-06714-w","volume":"51","author":"Y Tian","year":"2024","unstructured":"Tian Y, Shen H, Li L, Jia X, Liu J, Hu Z, Wang L, Tian J (2024) Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging. Eur J Nucl Med Mol Imaging 51:2569\u20132582. https:\/\/doi.org\/10.1007\/s00259-024-06714-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4403_CR25","doi-asserted-by":"publisher","first-page":"1684127","DOI":"10.1080\/2162402X.2019.1684127","volume":"9","author":"B Huang","year":"2020","unstructured":"Huang B, Luo L, Wang J, He B, Feng R, Xian N, Zhang Q, Chen L, Huang G (2020) B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models. Oncoimmunology 9:1684127. https:\/\/doi.org\/10.1080\/2162402X.2019.1684127","journal-title":"Oncoimmunology"},{"key":"4403_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm.2666","volume":"18","author":"MS Thu","year":"2012","unstructured":"Thu MS, Bryant LH, Coppola T et al (2012) Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med 18:463\u2013467. https:\/\/doi.org\/10.1038\/nm.2666","journal-title":"Nat Med"},{"key":"4403_CR27","doi-asserted-by":"publisher","first-page":"eadf2223","DOI":"10.1126\/sciimmunol.adf2223","volume":"9","author":"KO Dixon","year":"2024","unstructured":"Dixon KO, Lahore GF, Kuchroo VK (2024) Beyond T cell exhaustion: TIM-3 regulation of myeloid cells. Sci Immunol 9:eadf2223. https:\/\/doi.org\/10.1126\/sciimmunol.adf2223","journal-title":"Sci Immunol"},{"key":"4403_CR28","doi-asserted-by":"publisher","first-page":"e2300392","DOI":"10.1002\/smll.202300392","volume":"19","author":"Y Guo","year":"2023","unstructured":"Guo Y, Hu J, Wang P et al (2023) In vivo NIR-II fluorescence lifetime imaging of whole-body vascular using high quantum yield lanthanide-doped nanoparticles. Small 19:e2300392. https:\/\/doi.org\/10.1002\/smll.202300392","journal-title":"Small"},{"key":"4403_CR29","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/neuonc\/noy032","volume":"20","author":"SJ Bagley","year":"2018","unstructured":"Bagley SJ, Desai AS, Linette GP, June CH, O\u2019Rourke DM (2018) CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges. Neuro Oncol 20:1429\u20131438. https:\/\/doi.org\/10.1093\/neuonc\/noy032","journal-title":"Neuro Oncol"},{"key":"4403_CR30","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-15-0428","volume":"21","author":"CE Brown","year":"2015","unstructured":"Brown CE, Badie B, Barish ME et al (2015) Bioactivity and safety of IL13R\u03b12-redirected chimeric antigen receptor CD8+ T cells in patients with recurrent glioblastoma. Clin Cancer Res 21:4062\u20134072. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0428","journal-title":"Clin Cancer Res"},{"key":"4403_CR31","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41467-017-01830-8","volume":"8","author":"D Schmid","year":"2017","unstructured":"Schmid D, Park CG, Hartl CA et al (2017) T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. Nat Commun 8:1747. https:\/\/doi.org\/10.1038\/s41467-017-01830-8","journal-title":"Nat Commun"},{"key":"4403_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","volume":"20","author":"JN Sarkaria","year":"2018","unstructured":"Sarkaria JN, Hu LS, Parney IF et al (2018) Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol 20:184\u2013191. https:\/\/doi.org\/10.1093\/neuonc\/nox175","journal-title":"Neuro Oncol"},{"key":"4403_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","volume":"13","author":"NA Vitanza","year":"2023","unstructured":"Vitanza NA, Wilson AL, Huang W et al (2023) Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: preliminary first-in-human bioactivity and safety. Cancer Discov 13:114\u2013131. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0750","journal-title":"Cancer Discov"},{"key":"4403_CR34","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","volume":"375","author":"CE Brown","year":"2016","unstructured":"Brown CE, Alizadeh D, Starr R et al (2016) Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med 375:2561\u20132569. https:\/\/doi.org\/10.1056\/NEJMoa1610497","journal-title":"N Engl J Med"},{"key":"4403_CR35","doi-asserted-by":"publisher","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","volume":"191","author":"R Sun","year":"2022","unstructured":"Sun R, Xiang J, Zhou Q, Piao Y, Tang J, Shao S, Zhou Z, Bae YH, Shen Y (2022) The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. Adv Drug Deliv Rev 191:114614. https:\/\/doi.org\/10.1016\/j.addr.2022.114614","journal-title":"Adv Drug Deliv Rev"},{"key":"4403_CR36","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1038\/s41467-023-40579-1","volume":"14","author":"Q Cai","year":"2023","unstructured":"Cai Q, Li X, Xiong H et al (2023) Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment. Nat Commun 14:4934. https:\/\/doi.org\/10.1038\/s41467-023-40579-1","journal-title":"Nat Commun"},{"key":"4403_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jcyt.2020.10.006","volume":"23","author":"T Xie","year":"2021","unstructured":"Xie T, Chen X, Fang J et al (2021) Non-invasive monitoring of the kinetic infiltration and therapeutic efficacy of nanoparticle-labeled chimeric antigen receptor T cells in glioblastoma via 7.0-Tesla magnetic resonance imaging. Cytotherapy 23:211\u2013222. https:\/\/doi.org\/10.1016\/j.jcyt.2020.10.006","journal-title":"Cytotherapy"},{"key":"4403_CR38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1186\/s12967-025-07054-5","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu J, Cheng L, Ma C, Wang X, Ji X, Li Y, Liu J (2025) Clinical trials and advanced MRI techniques with stem cell therapy for ischemic stroke: present and future perspectives. J Transl Med 23:1069. https:\/\/doi.org\/10.1186\/s12967-025-07054-5","journal-title":"J Transl Med"},{"key":"4403_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41377-024-01450-0","volume":"13","author":"F Yang","year":"2024","unstructured":"Yang F, Wang Z, Shi W et al (2024) Advancing insights into in vivo meningeal lymphatic vessels with stereoscopic wide-field photoacoustic microscopy. Light Sci Appl 13:96. https:\/\/doi.org\/10.1038\/s41377-024-01450-0","journal-title":"Light Sci Appl"}],"updated-by":[{"DOI":"10.1007\/s00262-026-04501-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000}}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04403-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04403-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04403-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:37:46Z","timestamp":1787143066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04403-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4403"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04403-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9126411\/v1","asserted-by":"object"}]},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Figure 5 has been updated","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00262-026-04501-0","URL":"https:\/\/doi.org\/10.1007\/s00262-026-04501-0","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"160"}}